Skip to Content

Methocarbamol Tablets

Last Updated: April 16, 2020
Status: Current

Products Affected - Description
    • Robaxin oral tablet, Endo Pharmaceuticals, 500 mg, bottle, 100 count, NDC 52244-0429-10 - discontinued
    • Robaxin oral tablet, Endo Pharmaceuticals, 750 mg, bottle, 100 count, NDC 52244-0449-10 - discontinued
    • Methocarbamol oral tablet, Camber, 500 mg, bottle, 100 count, NDC 31722-0533-01
    • Methocarbamol oral tablet, Camber, 500 mg, bottle, 500 count, NDC 31722-0533-05
    • Methocarbamol oral tablet, Camber, 750 mg, bottle, 100 count, NDC 31722-0534-01
    • Methocarbamol oral tablet, Camber, 750 mg, bottle, 500 count, NDC 31722-0534-05
    • Methocarbamol oral tablet, Par Pharmaceuticals, 500 mg, bottle, 100 count, NDC 00603-4485-21 - discontinued
    • Methocarbamol oral tablet, Par Pharmaceuticals, 500 mg, bottle, 500 count, NDC 00603-4485-28 - discontinued
    • Methocarbamol oral tablet, Par Pharmaceuticals, 750 mg, bottle, 100 count, NDC 00603-4486-21 - discontinued
    • Methocarbamol oral tablet, Par Pharmaceuticals, 750 mg, bottle, 500 count, NDC 00603-4486-28 - discontinued
    • Methocarbamol oral tablet, Par Pharmaceuticals, 750 mg, bottle, 1000 count, NDC 00603-4486-32 - discontinued
    • Methocarbamol oral tablet, Virtus, 500 mg, bottle, 100 count, NDC 69543-0134-10 - discontinued
    • Methocarbamol oral tablet, Virtus, 500 mg, bottle, 500 count, NDC 69543-0134-50 - discontinued
    • Methocarbamol oral tablet, Virtus, 750 mg, bottle, 100 count, NDC 69543-0135-10 - discontinued
    • Methocarbamol oral tablet, Virtus, 750 mg, bottle, 500 count, NDC 69543-0135-50 - discontinued
Reason for the Shortage
    • Bayshore states the shortage is due to increased demand.
    • Camber states the shortage is due to an API shortage.
    • Endo discontinued Robaxin tablets in January 2020.
    • Granules has methocarbamol tablets available.
    • Hikma is not actively marketing methocarbamol tablets.
    • Par discontinued methocarbamol tablets in July 2018.
    • Solco states the shortage is due to an API shortage.
    • Virtus discontinued methocarbamol tablets in June 2019.
Available Products
    • Methocarbamol oral tablet, Bayshore, 500 mg, bottle, 100 count, NDC 76385-0123-01
    • Methocarbamol oral tablet, Bayshore, 500 mg, bottle, 500 count, NDC 76385-0123-50
    • Methocarbamol oral tablet, Bayshore, 750 mg, bottle, 100 count, NDC 76385-0124-01
    • Methocarbamol oral tablet, Bayshore, 750 mg, bottle, 500 count, NDC 76385-0124-50
    • Methocarbamol oral tablet, Granules, 500 mg, bottle, 100 count, NDC 62207-0754-43
    • Methocarbamol oral tablet, Granules, 500 mg, bottle, 500 count, NDC 62207-0754-47
    • Methocarbamol oral tablet, Granules, 750 mg, bottle, 100 count, NDC 62207-0770-43
    • Methocarbamol oral tablet, Granules, 750 mg, bottle, 500 count, NDC 62207-0770-47
    • Methocarbamol oral tablet, Solco Healthcare US, 500 mg, bottle, 100 count, NDC 43547-0405-10
    • Methocarbamol oral tablet, Solco Healthcare US, 500 mg, bottle, 500 count, NDC 43547-0405-50
    • Methocarbamol oral tablet, Solco Healthcare US, 750 mg, bottle, 100 count, NDC 43547-0226-10
    • Methocarbamol oral tablet, Solco Healthcare US, 750 mg, bottle, 500 count, NDC 43547-0226-50

Estimated Resupply Dates

    • Camber has all methocarbamol tablets available for contracted customers. All presentations are on allocation for non-contracted customers.

Updated

Updated April 16, 2020 by Leslie Jensen, PharmD, Drug Information Specialist. Created May 8, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide